4//SEC Filing
Dye Capital Cann Holdings, II 4
Accession 0001683168-21-002419
CIK 0001622879other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 3:58 PM ET
Size
20.1 KB
Accession
0001683168-21-002419
Insider Transaction Report
Form 4
Dye Capital Cann Holdings, II
10% Owner
Transactions
- Purchase
Series A Cumulative Convertible Preferred Stock
2020-12-16$1000.00/sh+7,700$7,700,000→ 7,700 totalExercise: $1.20→ Common Stock (6,416,667 underlying) - Purchase
Series A Cumulative Convertible Preferred Stock
2021-02-25$1000.00/sh+1,300$1,300,000→ 14,850 totalExercise: $1.20→ Common Stock (1,083,333 underlying) - Purchase
Series A Cumulative Convertible Preferred Stock
2020-12-22$1000.00/sh+1,300$1,300,000→ 10,450 totalExercise: $1.20→ Common Stock (1,083,333 underlying) - Purchase
Series A Cumulative Convertible Preferred Stock
2021-03-30$1000.00/sh+4,000$4,000,000→ 21,350 totalExercise: $1.20→ Common Stock (3,333,333 underlying) - Purchase
Series A Cumulative Convertible Preferred Stock
2021-03-02$1000.00/sh+2,500$2,500,000→ 17,350 totalExercise: $1.20→ Common Stock (2,083,333 underlying) - Purchase
Series A Cumulative Convertible Preferred Stock
2021-02-03$1000.00/sh+3,100$3,100,000→ 13,550 totalExercise: $1.20→ Common Stock (2,583,333 underlying) - Purchase
Series A Cumulative Convertible Preferred Stock
2020-12-18$1000.00/sh+1,450$1,450,000→ 9,150 totalExercise: $1.20→ Common Stock (1,208,333 underlying)
Footnotes (3)
- [F1]Subject to adjustment, as described in the Certificate of Designation.
- [F2]The shares of Series A Cumulative Convertible Preferred Stock (the "Series A Preferred Shares") are convertible into shares of the common stock (the "Common Shares") of Medicine Man Technologies, Inc. (the "Company") upon the events specified in the Company's Certificate of Designation of Series A Cumulative Convertible Preferred Stock (the "Certificate of Designation"). The Preferred stock is perpetual and therefore has no expiration date.
- [F3]Represents the number of Common Shares issuable upon conversion of the Series A Preferred Shares on the date of the reported transaction. Each Series A Preferred Share is convertible into that number of Common Shares equal to the preference amount (initially $1,000) plus any accrued dividends with respect to such share, divided by the conversion price (initially $1.20), subject to adjustment as set forth in the Certificate of Designation. The Series A Preferred Shares earn a cumulative dividend of 8% per annum.
Documents
Issuer
Medicine Man Technologies, Inc.
CIK 0001622879
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001863966
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 3:58 PM ET
- Size
- 20.1 KB